Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine

Characterization and use of human brain microvascular endothelial cells to examine β-amyloid exchange in the blood-brain barrier

(2010) Corbin Bachmeier et al.   CYTOTECHNOLOGY

Blood–brain barrier penetration of the enantiomers of venlafaxine and its metabolites in mice lacking P-glycoprotein

(2010) Louise Karlsson et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Comparison of the Pharmacokinetics of Venlafaxine Extended Release and Desvenlafaxine in Extensive and Poor Cytochrome P450 2D6 Metabolizers

(2009) Sheldon Preskorn et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs

(2009) Sarah Shugarts et al.   PHARMACEUTICAL RESEARCH

Venlafaxine–Propafenone Interaction Resulting in Hallucinations and Psychomotor Agitation

(2008) Pietro Gareri et al.   ANNALS OF PHARMACOTHERAPY

An Assessment of Drug-Drug Interactions: The Effect of Desvenlafaxine and Duloxetine on the Pharmacokinetics of the CYP2D6 Probe Desipramine in Healthy Subjects

(2008) A. Patroneva et al.   DRUG METABOLISM AND DISPOSITION

The Effects of Desvenlafaxine and Paroxetine on the Pharmacokinetics of the Cytochrome P450 2D6 Substrate Desipramine in Healthy Adults

(2008) Alice I. Nichols et al.   JOURNAL OF CLINICAL PHARMACOLOGY